Back
Aligos Therapeutics Stock Price Chart
Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
41
ALGS
Aligos Therapeutics
Last Price:
$7.69
Seasonality Move:
-9.63%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
The current trend is moderately bullish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.
Aligos Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.8 | Sell |
| 20-day SMA: | 6.7 | Buy |
| 50-day SMA: | 5.79 | Buy |
| 200-day SMA: | 15.57 | Sell |
| 8-day EMA: | 7.63 | Sell |
| 20-day EMA: | 7 | Buy |
| 50-day EMA: | 7.47 | Buy |
| 200-day EMA: | 13.66 | Sell |
Aligos Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 56.62 | Buy |
| Chaikin Money Flow: | -152862 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.53 - 7.53) | Buy |
| Bollinger Bands (100): | (3.79 - 17.87) | Sell |
Aligos Therapeutics Technical Analysis
| Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aligos Therapeutics Stock
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 7.55 while ALGS 8-day simple moving average is 7.80, which is a Sell signal.
-
The stock price of ALGS is 7.55 while Aligos Therapeutics 20-day SMA is 6.70, which makes it a Buy.
-
Aligos Therapeutics 50-day simple moving average is 5.79 while ALGS share price is 7.55, making it a Buy technically.
-
ALGS stock price is 7.55 and Aligos Therapeutics 200-day simple moving average is 15.57, creating a Sell signal.
ALGS Technical Analysis vs Fundamental Analysis
Sell
41
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a SellThe current Aligos Therapeutics [ALGS] share price is $7.55. The Score for ALGS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Aligos Therapeutics Stock Info
Market Cap:
46.2M
Price in USD:
7.55
Share Volume:
152.9K
Aligos Therapeutics 52-Week Range
52-Week High:
46.80
52-Week Low:
3.76
Sell
41
Aligos Therapeutics (ALGS)
is a Sell
Aligos Therapeutics Share Price Forecast
-
What is the Aligos Therapeutics stock price today?The Aligos Therapeutics stock price is 7.55 USD today.
-
Will ALGS stock go up or go down?Aligos Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aligos Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics is overvalued.
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 7.55 while ALGS 8-day exponential moving average is 7.63, which is a Sell signal.
-
The stock price of ALGS is 7.55 while Aligos Therapeutics 20-day EMA is 7.00, which makes it a Buy.
-
Aligos Therapeutics 50-day exponential moving average is 7.47 while ALGS share price is 7.55, making it a Buy technically.
-
ALGS stock price is 7.55 and Aligos Therapeutics 200-day simple moving average is 13.66, creating a Sell signal.
Fundamental Analysis of Aligos Therapeutics
Is Aligos Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
Technical Analysis of Aligos Therapeutics
Should I short Aligos Therapeutics stock?
-
ALGS Moving Average Covergence Divergence (MACD) indicator is 0.54, suggesting Aligos Therapeutics is a Buy
-
Aligos Therapeutics Relative Strength Index (RSI) is 56.62, which suggest Aligos Therapeutics is overbought
-
The Bollinger Bands (25) for Aligos Therapeutics is (5.53 - 7.53), which suggest Aligos Therapeutics is a Sell
-
The Bollinger Bands (100) for Aligos Therapeutics is (3.79 - 17.87), which suggest Aligos Therapeutics is a Sell
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.